Figure 3.

MRL‐Fas^lpr transferred with tolerogenic dendritic cells (tolDCs) show a reduction in their clinical score. Mice were monitored for 60–70 days from the beginning of the experiment. Clinical scores of mice from all experimental groups were recorded three times per week; the figure shows the average of the clinical score per group until 10 days after the last transfer. (a) MRL‐Fas^lpr and (b) NZM2410 mice transferred are shown. *P < 0·05, **P < 0·01, ***P < 0·001 by one‐way or two‐way analysis of variance test and Bonferroni post‐test. Data are shown as the mean ± standard error (for three or four animals per group depending on the case).